Graduate School of Medicine, Kyoto University has its research center on the campus of Universi...

Rebirthel Co., Ltd. announces that it entered into an exclusive commercial licensing agreement ...

In the morning edition of Nihon Keizai Shimbun on October 22nd, 2021 (Page 18, Technology), Reb...

Rebirthel participated in the exhibition “Japan Healthcare Venture Summit 2021 (JHVS2021)”, hel...

“The dictionary of Biotech Startups in Japan 2021-2022” which covers over 400 bio venture compa...

Professor Hiroshi Kawamoto, an executive director of Rebirthel, appeared on the morning news pr...

“Forest of Industry-Academia-Government” is the subsidy program to support industry-academia co...

Professor Hiroshi Kawamoto’s laboratory, Kyoto University, made an exhibition of its research a...

Professor Hiroshi Kawamoto, an executive director of Rebirthel and the Vice Director of Institu...

In the evening edition of Sankei Shimbun on May 15th, 2021, Professor Hiroshi Kawamoto’s resear...